Brokerages Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) Price Target at $95.46

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has received a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $95.46.

GEHC has been the subject of a number of research analyst reports. Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price target for the company. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price objective for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Stifel Nicolaus boosted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. Finally, Wells Fargo & Company increased their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st.

GE HealthCare Technologies Trading Up 2.7 %

Shares of GEHC stock opened at $80.52 on Friday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The company has a market capitalization of $36.79 billion, a price-to-earnings ratio of 22.12, a PEG ratio of 2.90 and a beta of 1.07. GE HealthCare Technologies has a 52-week low of $71.31 and a 52-week high of $94.55. The company has a 50-day simple moving average of $82.45 and a two-hundred day simple moving average of $83.98.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. GE HealthCare Technologies’s quarterly revenue was up .9% on a year-over-year basis. During the same period in the prior year, the company posted $0.99 earnings per share. Research analysts anticipate that GE HealthCare Technologies will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.17%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.30%.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.27% of the company’s stock.

Institutional Trading of GE HealthCare Technologies

Institutional investors and hedge funds have recently made changes to their positions in the stock. D1 Capital Partners L.P. purchased a new position in shares of GE HealthCare Technologies during the third quarter worth approximately $268,159,000. Van ECK Associates Corp bought a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at $208,513,000. State Street Corp raised its position in GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after purchasing an additional 1,347,114 shares during the period. Massachusetts Financial Services Co. MA purchased a new stake in GE HealthCare Technologies during the third quarter valued at about $93,713,000. Finally, Marshall Wace LLP bought a new position in shares of GE HealthCare Technologies during the second quarter valued at about $63,639,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.